Recent BioUtah News & Events

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]

Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies

Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.

rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools

The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.

EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM

Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients

REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.

Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence

Myriad Genetics announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.

Ultradent Products is being recognized for the third consecutive year as a Fortune Magazine Top Large Workplace in Manufacturing and Production.

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]

19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]

In a recent interview with BioTuesdays, Halia and Co-Founder David Bearss, P.HD., said that the company is “growing to become a leader in targeting the NLRP3 inflammasome through a unique mechanism of action.” Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential […]

Crews to topple final guard tower and showcase sustainable demolition practices   WHAT: Members of the media are invited to get a close-up look at demolition efforts currently underway at The Point. Attendees will get exclusive views of the preserved prison chapel called the “Chapel by the Wayside” and the state-of-the-art crushing facility used to […]

It was standing room only Tuesday as Halia Therapeutics held a ribbon cutting for the opening of its new headquarters in Lehi, Utah – a 20,000 square foot state-of-art drug research and development facility. CEO and co-founder, David Bearss, Ph.D. welcomed guests and shared the Halia mission: to develop novel therapies to improve the lives […]

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the […]

Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

By Kelvyn Cullimore For the Deseret News

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]